| abstract |
The present invention relates to a soluble multidomain binding molecule comprising a T cell receptor (TCR), an immunoglobulin Fc domain or an albumin-binding moiety; and an immunoeffector domain having specificity for an antigen. Such multi-domain binding molecules are advantageous because they exhibit an improved half-life while preserving function. [Selection diagram] None |